Page last updated: 2024-11-05

dimethyltin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID31651
CHEBI ID30539
MeSH IDM0118833

Synonyms (20)

Synonym
dimethyltin
23120-99-2
dimethyl-lambda(2)-stannane
[snme2]
dimethylstannylene
CHEBI:30539
snme2
dimethyltin(ii)
nsc-22307
nsc22307
tin, dimethyl-
stannylene, dimethyl-
unii-2gvk75k8ef
2gvk75k8ef ,
PWEVMPIIOJUPRI-UHFFFAOYSA-N
dimethyl tin
dimethyltin(iv)
DTXSID10177691
dimethylzinn
Q27113858
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
organotin compound
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (33)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (3.03)18.7374
1990's7 (21.21)18.2507
2000's17 (51.52)29.6817
2010's8 (24.24)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.79

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.79 (24.57)
Research Supply Index3.56 (2.92)
Research Growth Index5.26 (4.65)
Search Engine Demand Index43.64 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.79)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.94%)6.00%
Case Studies1 (2.94%)4.05%
Observational0 (0.00%)0.25%
Other32 (94.12%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]